Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

New alopecia Rx tested in patients

Dec. 18, 1996

Piliel enters pivotal trials in Europe

Dec. 18, 1996

Protein Polymer Technologies and Ethicon extend R&D collaboration

Dec. 17, 1996

Glaxo Wellcome granted license to Cellegy orphan drug

Dec. 16, 1996

Advanced Polymer Systems to supply Johnson & Johnson with Microsponge-entrapped AHAs

Dec. 16, 1996

First marketing approval for Allergan antipsoriatic

Dec. 13, 1996

Vertex selects lead development candidate for autoimmune diseases

Dec. 13, 1996

hu1124 advances to clinical studies

Dec. 12, 1996

OsmoCyte approved for marketing in U.S.

Dec. 9, 1996

Dusa photodynamic therapy advances to phase III

Dec. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...